Cargando…

Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags

PURPOSE: Calcium levofolinate (CaLev) for intravenous administration is commercially available as a powder that must be reconstituted for injection or reconstituted and then diluted before administration. The lack of stability data on CaLev solutions renders necessary extemporaneous manual preparati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanogo, Seydou, Silimbani, Paolo, Gaggeri, Raffaella, Masini, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903855/
https://www.ncbi.nlm.nih.gov/pubmed/32299315
http://dx.doi.org/10.1177/1078155220918025
_version_ 1783654817782038528
author Sanogo, Seydou
Silimbani, Paolo
Gaggeri, Raffaella
Masini, Carla
author_facet Sanogo, Seydou
Silimbani, Paolo
Gaggeri, Raffaella
Masini, Carla
author_sort Sanogo, Seydou
collection PubMed
description PURPOSE: Calcium levofolinate (CaLev) for intravenous administration is commercially available as a powder that must be reconstituted for injection or reconstituted and then diluted before administration. The lack of stability data on CaLev solutions renders necessary extemporaneous manual preparation, preventing the use of automated/semi-automated systems, with a consequent loss in terms of quality and safety. METHODS: The present work assessed the chemical–physical and microbiological stability of CaLev prepared in sodium chloride 0.9%, glucose 5% and water for injections and stored in polyolefin/polyamide bags and polypropylene syringes at 2–8°C protected from light. For this purpose, we developed and validated a new rapid High Performance Liquid Chromatography with Ultra Violet Diode-Array Detection (HPLC-UV-DAD) method. RESULTS: The samples tested were stable for 14 days, retaining >95% of their initial concentration and showing no change in colour, turbidity or pH. Microbiological tests performed on the samples were negative. CONCLUSIONS: Our results confirmed the analytical stability of CaLev in NaCl 0.9%, glucose 5% and water for injection at concentrations used in clinical practice at our institute. This enables our centralized laboratory to organize the preparation of this drug in advance and the use of robots rather than manual preparation reduces the workload and the risk of preparation errors.
format Online
Article
Text
id pubmed-7903855
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79038552021-03-11 Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags Sanogo, Seydou Silimbani, Paolo Gaggeri, Raffaella Masini, Carla J Oncol Pharm Pract Original Articles PURPOSE: Calcium levofolinate (CaLev) for intravenous administration is commercially available as a powder that must be reconstituted for injection or reconstituted and then diluted before administration. The lack of stability data on CaLev solutions renders necessary extemporaneous manual preparation, preventing the use of automated/semi-automated systems, with a consequent loss in terms of quality and safety. METHODS: The present work assessed the chemical–physical and microbiological stability of CaLev prepared in sodium chloride 0.9%, glucose 5% and water for injections and stored in polyolefin/polyamide bags and polypropylene syringes at 2–8°C protected from light. For this purpose, we developed and validated a new rapid High Performance Liquid Chromatography with Ultra Violet Diode-Array Detection (HPLC-UV-DAD) method. RESULTS: The samples tested were stable for 14 days, retaining >95% of their initial concentration and showing no change in colour, turbidity or pH. Microbiological tests performed on the samples were negative. CONCLUSIONS: Our results confirmed the analytical stability of CaLev in NaCl 0.9%, glucose 5% and water for injection at concentrations used in clinical practice at our institute. This enables our centralized laboratory to organize the preparation of this drug in advance and the use of robots rather than manual preparation reduces the workload and the risk of preparation errors. SAGE Publications 2020-04-16 2021-03 /pmc/articles/PMC7903855/ /pubmed/32299315 http://dx.doi.org/10.1177/1078155220918025 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Articles
Sanogo, Seydou
Silimbani, Paolo
Gaggeri, Raffaella
Masini, Carla
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title_full Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title_fullStr Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title_full_unstemmed Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title_short Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
title_sort stability of calcium levofolinate reconstituted in syringes and diluted in nacl 0.9% and glucose 5% polyolefin/polyamide infusion bags
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903855/
https://www.ncbi.nlm.nih.gov/pubmed/32299315
http://dx.doi.org/10.1177/1078155220918025
work_keys_str_mv AT sanogoseydou stabilityofcalciumlevofolinatereconstitutedinsyringesanddilutedinnacl09andglucose5polyolefinpolyamideinfusionbags
AT silimbanipaolo stabilityofcalciumlevofolinatereconstitutedinsyringesanddilutedinnacl09andglucose5polyolefinpolyamideinfusionbags
AT gaggeriraffaella stabilityofcalciumlevofolinatereconstitutedinsyringesanddilutedinnacl09andglucose5polyolefinpolyamideinfusionbags
AT masinicarla stabilityofcalciumlevofolinatereconstitutedinsyringesanddilutedinnacl09andglucose5polyolefinpolyamideinfusionbags